… 目前表皮生长因子酪氨酸激酶抑制剂（epidermal growth factor receptor tyrosine kinase inhibitor,
EGFR-TKI）已广泛应用于非小细胞肺癌（non-small cell lung cancer, NSCLC）患者，但如何将…

… The efficacy of non-small cell lung cancer (NSCLC) has been obviously improved recent
years, while the survival of small cell lung cancer (SCLC) patients … Second line or beyond …

… Abstract: Objective To review the effectiveness and safety of … 及 不良反应发生率采用相对危险
度(relative risk, RR)及其95%CI… second-line treatment of advanced non-smallcell lung cancer[…

… 60 patients with non-small cell lung cancer were selected from … as second-line therapy in
patients with non-small-cell lung … A comparative study on inflammatory factors and immune …

… in non-small cell lung cancer patients treated with anti-programmed … Impact of tumor
microenvironment on the efficacy of … for treatment with pembrolizumab as a second line treatment …

… Meta分析,比较ICIs相关的甲状腺功能异常的发生 率和相对危险度(relative risk,RR). 1 资料与方法
… as second-line treatment in advanced or metastatic squamous nonsmall-cell lung cancer: …

… events showed that the relative risks of severe diarrhea … second‑ line treatment of advanced
hepatocellular carcinoma[J… or metastatic non‑small‑cell lung cancer following first‑line …

… To analyze the clinical efficacy and safety of ursodeoxycholic … Editorial: fenofibrate as
second-line therapy in high risk PBC-… assisted thoracoscope for non-small cell lung cancer is a …